Shopping Cart
- Remove All
- Your shopping cart is currently empty
TREM2-IN-1 (OPA) is a platinum-based TREM2 inhibitor with anti-cancer activity, blocking DNA replication and inhibiting TREM2 on myeloid cells. It suppresses immune regulatory activity, reducing CD206 and CX3CR1 in a mouse model of colorectal cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $1,270 | In Stock | |
10 mg | Inquiry | 1-2 weeks | |
50 mg | Inquiry | 1-2 weeks |
Description | TREM2-IN-1 (OPA) is a platinum-based TREM2 inhibitor with anti-cancer activity, blocking DNA replication and inhibiting TREM2 on myeloid cells. It suppresses immune regulatory activity, reducing CD206 and CX3CR1 in a mouse model of colorectal cancer. |
In vitro | TREM2-IN-1 (0.8 μM, 72 h) inhibited the early phase of DNA synthesis (G1 phase) in HCT-116 cells and had a strong pro-apoptotic ability. Trem2-in-1 (1 μM, 24 h) significantly inhibited the expression of TREM2 IN THP-1-derived macrophages. [1] |
In vivo | TREM2-IN-1 (1.5 mg Pt per kg, treated, a single dose, lasting 15 days) was effective in inhibiting tumor growth in a C57BL/6 mouse model with MC38 mouse colon cancer and was less toxic overall. [1] |
Molecular Weight | 1164.12 |
Formula | C46H68N2O20Pt |
Cas No. | 2000236-36-0 |
Smiles | [O-](C(CCC(O[C@@H]1O[C@]2([C@]34[C@]([C@H]1C)(CC[C@@H](C)[C@@]3(CC[C@](C)(O2)OO4)[H])[H])[H])=O)=O)[Pt+4]56([O-]C(CCC(O[C@@H]7O[C@]8([C@]9%10[C@]([C@H]7C)(CC[C@@H](C)[C@@]9(CC[C@](C)(O8)OO%10)[H])[H])[H])=O)=O)([NH2]C%11C([NH2]5)CCCC%11)[O-]C(=O)C(=O)[O-]6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (68.72 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.